The specific findings and implications are as follows: EIF4EBP1: While recognized as a key downstream regulator of the mTOR pathway and implicated in tumor growth in cancers such as breast and ewing sarcoma tumors [32,33], our study is the first to reveal its significant upregulation and potential diagnostic value in cSCC. The gene discussed is EIF4EBP1; the disease is cancer.